"The study is an 18-patient single-dose, randomised, open-label, 2-treatment, 2-period crossover study of
SPONTAN nasal spray (5 mg Vardenafil) compared to Vardenafil tablets (10 mg Vardenafil) in healthy adult male
subjects under fasting conditions."
So just wondering how they actually test the validity of the results.. is it anecdotal or are observers required?
So many questions...
Ann: First patients dosed in SPONTAN pivotal study, page-5
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.080(4.97%) |
Mkt cap ! $143.2M | |||
| Open | High | Low | Value | Volume |
| $1.64 | $1.71 | $1.57 | $1.078M | 659.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2641 | $1.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.71 | 1616 | 2 |
View Market Depth
| Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
| LTP (ASX) Chart |